Financials
Income statement
| Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.9M | 17.7M | 17.7M | 18.4M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 6.1M | 6.3M | 6.3M | 6.4M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 6.2M | 7.8M | 7.6M | 7.9M |
| Tax provision | 1.8M | 2.2M | 2.2M | 2.3M |
| Net income | 4.5M | 5.6M | 5.5M | 5.7M |
| Basic EPS | 0.4 | 0.5 | 0.5 | 0.5 |
| Diluted EPS | 0.4 | 0.5 | 0.5 | 0.5 |
| Basic average shares | 10.6M | 10.6M | 10.6M | 10.6M |
| Diluted average shares | 10.6M | 10.6M | 10.6M | 10.6M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |